Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD

NCT06449092 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06449092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06449092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2025
Completion date
January 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

detect the significance of remnant cholesterol in detection severity of mafld